Jan-Åke Liljeqvist Selected Research

Jan-Åke Liljeqvist Research Topics

15	Infections 02/2022 - 04/2011
3	COVID-19 01/2022 - 01/2020
1	Herpes Genitalis (Genital Herpes) 01/2021
1	Persistent Infection 03/2020
1	Measles 04/2019
1	Breakthrough Infections 04/2019
1	Leukemia 01/2018
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2018
1	Herpes Simplex 05/2015
1	Disease Progression 11/2014
1	Coinfection 01/2014
1	Meningitis 04/2011

7	Immunoglobulin G (IgG)IBA 02/2022 - 01/2018
6	AntibodiesIBA 02/2022 - 11/2014
5	VaccinesIBA 01/2021 - 07/2012
3	Glycoproteins (Glycoprotein)IBA 01/2021 - 07/2012
1	delta inulinIBA 01/2021
1	Hepatitis B AntigensIBA 03/2020
1	RNA (Ribonucleic Acid)IBA 04/2019
1	Histamine (Histamine Dihydrochloride)FDA Link 01/2018
1	Interleukin-2 (IL2)IBA 01/2018
1	Interleukin-4 (Interleukin 4)IBA 01/2017
1	Interleukin-10 (Interleukin 10)IBA 01/2017
1	GlycosaminoglycansIBA 02/2016
1	OligosaccharidesIBA 02/2016
1	Proteoglycans (Proteoglycan)IBA 02/2016
1	Progesterone FDA LinkGeneric 05/2015
1	Anti-Infective Agents (Microbicides)IBA 05/2015
1	Monoclonal AntibodiesIBA 11/2014
1	EnzymesIBA 01/2014
1	AntigensIBA 04/2011
1	CytokinesIBA 04/2011